Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Edity Therapeutics

Company Type: Therapeutics

Main focus: Immune cell engineering to deliver therapeutics to diseased cells

Company stage: Pre-clinical

Diseases: Cancer and genetic disease

Genome-editing tool:

Funding stage: Pre-Seed

Location: Rehovot, HaMerkaz, Israel

Website: https://edity-tx.com/

Pipeline:

Partners:

Edity Therapeutics is developing a new therapeutic platform that takes advantage of the natural ability of immune cells to release cargo (e.g. lytic payloads) within the cells they dock with. Edity Therapeutics plans to swap the natural cargo with a therapeutic payload which can then be released into the target cells.

Tags

HashtagEdity Therapeutics

Company: Edity Therapeutics
close
Search CRISPR Medicine